Loading data
CHYMNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 2.19 bn USD | 1.67 bn USD | 1.28 bn USD |
| Cost of revenue | 263.05 m USD | 207.51 m USD | 219.74 m USD |
| Gross profit | 1.92 bn USD | 1.47 bn USD | 1.06 bn USD |
| Research and development expense | 934.93 m USD | 309.58 m USD | 259 m USD |
| Operating profit | -1.04 bn USD | -62.2 m USD | -235.79 m USD |
| Profit before tax | -1.01 bn USD | -22.73 m USD | -202.97 m USD |
| Income tax expense | 831 k USD | 2.61 m USD | 234 k USD |
| Net income (reported basis) | -1.01 bn USD | -25.34 m USD | -203.2 m USD |
| Basic earnings per share | -4.27 USD/share | -0.39 USD/share | -3.22 USD/share |
| Diluted earnings per share | -4.27 USD/share | -0.39 USD/share | -3.22 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.